1-3 of 3
Michael W. Becker
Close
Sort by
Journal Articles

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes

Marissa LoCastro, Andrea M. Baran, Jane L. Liesveld, Eric Huselton, Michael W. Becker, Kristen Marie O’Dwyer, Omar S. Aljitawi, Megan Baumgart, Eric Snyder, Benzi Kluger, Kah Poh Loh, Jason H. Mendler
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5554–5564.
https://doi.org/10.1182/bloodadvances.2021004775
Published: 2021
Journal Articles

Decisional involvement and information preferences of patients with hematologic malignancies

Kah Poh Loh, Mazie Tsang, Thomas W. LeBlanc, Anthony Back, Paul R. Duberstein, Supriya Gupta Mohile, Ronald M. Epstein, Heidi D. Klepin, Michael W. Becker, Areej El-Jawahri, Stephanie J. Lee
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5492–5500.
https://doi.org/10.1182/bloodadvances.2020003044
Published: 2020
Journal Articles

Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells

Laura M. Bystrom, Daniel P. Bezerra, Hsiao-Ting Hsu, Hongliang Zong, Luis A. Lara-Martínez, Jeanne P. De Leon, Megan Emmanuel, David Méry, Sara Gardenghi, Duane Hassane, Catherine C. Neto, Susanna Cunningham-Rundles, Michael W. Becker, Stefano Rivella, Monica L. Guzman
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3261–3265.
https://doi.org/10.1182/bloodadvances.2018026633
Published: 2019
Includes: Supplemental data